EUVIMEDEUVIMED entdecken
Open Access

Cerebrospinal Fluid Aβ Biomarkers Predict Recurrent Hemorrhage and Identify Cerebral Amyloid Angiopathy in Patients With Lobar Hemorrhage

Philipp Arndt iD, Malte Pfister, Frank Schreiber iD, Valentina Perosa iD, Hendrik Mattern iD, Jose Bernal iD, Berkant Bay, Marc Dörner iD, Marwa Al-Dubai, Vanessa Swiatek, Belal Neyazi iD, Erol Sandalcioglu iD und 6 weitere

Journal of the American Heart Association · 05.08.2025 · 14 (15)

DOI: 10.1161/jaha.124.042614 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 05.08.2025. Verfasst von Philipp Arndt und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Otto-von-Guericke University Magdeburg Germany. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Amyloid beta-Peptides, Peptide Fragments, Cerebral Hemorrhage. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recurrent hemorrhage represents a significant risk for patients with lobar hemorrhage and underlying cerebral amyloid angiopathy. However, it remains unknown, whether cerebrospinal fluid biomarkers of β‐amyloid (Aβ) retention, predict recurrent hemorrhagic events in these patients.

Methods

In this retrospective study, we evaluated patients with first‐ever lobar intracerebral hemorrhage or convexity subarachnoid hemorrhage who underwent cerebrospinal fluid analysis of Aβ 40 , Aβ 42 , and Aβ 42/40 ratio. Biomarker levels were compared between patients with and without recurrent hemorrhage, and optimal cutoff values were derived from receiver operating characteristic analysis to define high and low biomarker groups. Negative binomial regression models, adjusted for age, sex, and hypertension, were used to assess associations with recurrent hemorrhage rates, and Kaplan–Meier survival analysis evaluated time to first event as a sensitivity measure.

Results

Among 289 patients with lobar hemorrhage, 48 were eligible for analysis (mean age, 72.4 years; 44% women; median follow‐up, 2.7 years). Patients with recurrent hemorrhage had significantly lower Aβ 40 and Aβ 42 levels ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral Amyloid AngiopathyAmyloid beta-PeptidesPeptide FragmentsCerebral HemorrhageSubarachnoid HemorrhageHumansMaleFemaleBiomarkersRecurrenceAgedRetrospective StudiesMiddle AgedPredictive Value of TestsAged, 80 and overRisk FactorsPrognosis

Stichwörter der Autor:innen

amyloid βaβ positivitycerebral amyloid angiopathycerebrospinal fluidconvexity subarachnoid hemorrhagelobar intracerebral hemorrhagemixed intracerebral hemorrhage

Substanzen

Amyloid beta-PeptidesBiomarkersPeptide Fragmentsamyloid beta-protein (1-40)amyloid beta-protein (1-42)amyloid beta-protein (40-42)

Autor:innen und Institutionen

  • Department of Neurology Otto-von-Guericke University Magdeburg Germany.
  • German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association Magdeburg Germany.
  • J. Philip Kistler Stroke Research Center Massachusetts General Hospital/Harvard Medical School Boston MA USA.
  • Biomedical Magnetic Resonance, Faculty of Natural Sciences Otto-von-Guericke University Magdeburg Germany.
  • Center for Behavioral Brain Sciences Magdeburg Germany.
  • Institute of Cognitive Neurology and Dementia Research, Otto-Von-Guericke University Magdeburg Magdeburg Germany.

ORCID-Profile: Philipp Arndt, Frank Schreiber, Valentina Perosa, Hendrik Mattern, Jose Bernal, Marc Dörner, Belal Neyazi, Erol Sandalcioglu, Sven G Meuth, Stefanie Schreiber

Zitieren

APA

Arndt, P., Pfister, M., Schreiber, F., Perosa, V., Mattern, H., Bernal, J., Bay, B., Dörner, M., Al-Dubai, M., Swiatek, V., Neyazi, B., Sandalcioglu, E., Garz, C., Meuth, S. G., Goertler, M., Vielhaber, S., Neumann, K., & Schreiber, S. (2025). Cerebrospinal Fluid Aβ Biomarkers Predict Recurrent Hemorrhage and Identify Cerebral Amyloid Angiopathy in Patients With Lobar Hemorrhage. Journal of the American Heart Association, 14(15). https://doi.org/10.1161/jaha.124.042614

Vancouver

Arndt P, Pfister M, Schreiber F, Perosa V, Mattern H, Bernal J, et al. Cerebrospinal Fluid Aβ Biomarkers Predict Recurrent Hemorrhage and Identify Cerebral Amyloid Angiopathy in Patients With Lobar Hemorrhage. Journal of the American Heart Association. 2025;14(15). doi:10.1161/jaha.124.042614

BibTeX
@article{Arndt2025,
  author = {Arndt, Philipp and Pfister, Malte and Schreiber, Frank and Perosa, Valentina and Mattern, Hendrik and Bernal, Jose and Bay, Berkant and Dörner, Marc and Al-Dubai, Marwa and Swiatek, Vanessa and Neyazi, Belal and Sandalcioglu, Erol and Garz, Cornelia and Meuth, Sven G and Goertler, Michael and Vielhaber, Stefan and Neumann, Katja and Schreiber, Stefanie},
  title = {Cerebrospinal Fluid Aβ Biomarkers Predict Recurrent Hemorrhage and Identify Cerebral Amyloid Angiopathy in Patients With Lobar Hemorrhage},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {15},
  doi = {10.1161/jaha.124.042614}
}
Kostenlos starten →